Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

INSANE: 21 | Rare Historical Photos

Weight-loss drug use could boost GDP in US by 1%, says Goldman Sachs

Some analysts predict market could reach $100bn a year by end of decade with Eli Lilly and Ozempic maker Novo Nordisk leading

The Guardian - US

CNBC To Air Documentary on Weight-Loss Drug Ozempic

Melissa Lee reports for ‘Big Shot: The Ozempic Revolution,’ debuting Feb. 29

Multichannel News

Europe's Most Valuable Stock Is a Must-Own Near 52-Week Highs

Despite concerns over its ability to meet surging semaglutide demand, this Danish pharmaceutical giant holds a dominant position in the diabetes and insulin markets - and now commands the lead in Europe's stock market, too. Here's why NVO is a must-own stock.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

It's Not Too Late to Buy Eli Lilly Stock. Here's Why.

J.P. Morgan thinks sales of weight-loss drugs could exceed $100 billion by 2030. That's good news for Eli Lilly, which is now the largest pharma company by market capitalization and the 9th-biggest S&P 500 stock. Here's why LLY stock looks poised to put on even more weight in the months…

Barchart

Weight-loss drugs need to become cheaper, says AstraZeneca boss

Loss of muscle mass also flagged, as UK drugmaker works with China’s Eccogene on obesity and type 2 diabetes pill

The Guardian - UK

Novo Nordisk vs. Eli Lilly: Which Mega-Cap Healthcare Stock is a Better Buy for 2024?

Healthcare stocks LLY and NVO have crushed broader market returns in the past two decades. But with competition heating up over obesity drugs, which mega-cap stock is a better buy today?

Barchart

Pharma Stock Analysis: Buy, Hold, or Sell These 4?

Amid rising global medical needs, an aging population, and technological advancements, the pharmaceutical industry is expected to witness robust growth over the coming years. Given this positive backdrop, let’s analyze the investment prospects of pharma stocks Madrigal (MDGL), Pfizer (PFE), Astellas (ALPMY), and Novo Nordisk (NVO). Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Obesity drug boom pushes Novo Nordisk shares to record high

Market value of Danish drugmaker behind Wegovy and Ozempic tops $500bn as demand soars

The Guardian - UK

Weight-loss Drug Maker Novo Nordisk's Profit Surges As Sales Boom

Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday, driven by blockbuster sales of diabetes and obesity treatments that helped it become Europe's most valuable company.

International Business Times

UK house prices rise in January, Novo Nordisk obesity drug sales surge – as it happened

Nationwide says housing market looks ‘more positive’ as prices rise 0.7%; the Danish maker of Ozempic and Wegovy predicts further strong growth in 2024

The Guardian - UK

2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter

Five pharma companies will have sales that exceed $50 billion this year.

Kiplinger

"Faux-zempic" driving hospitalizations

Experts warn against the risks of illegitimately obtained Ozempic and Wegovy

Salon

3 Pharma Stocks for January 2024 Profits

The pharmaceutical industry is thriving, fueled by steady demand for drugs, cost-efficient alternative discoveries, and rapid technological innovations. Hence, fundamentally strong pharma stocks Novo Nordisk (NVO), Eton Pharmaceuticals (ETON), and Pacira BioSciences (PCRX) might be profitable buys now. Read on….

StockNews.com

Will weight loss drugs kill the fast food business?

Many firms see the dire forecasts as ‘overblown’ but they know they will have to adapt products to make ‘every bite counts’

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

Ozempic and Wegovy Show Lower Risk of Suicidal Thoughts

Hold onto your hats, folks, because there's some fascinating news in the world of diabetes and obesity drugs! A recent federal study found that people taki...

The Independent UK

People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds

A new federal study finds that people taking popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions

Barchart

Eli Lilly Stock: Buy or Sell?

Eli Lilly's diversified portfolio and high demand for its weight-loss drugs have pushed it to the top of Wall Street's list of top pharma stocks for 2024. Is now the time to buy?

Kiplinger

Insulin Now Available for $35 a Month for Many Americans

Insulin price caps from Eli Lilly, Novo Nordisk and Sanofi take effect this month.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

The Guardian view on anti-obesity drugs: treating a disease that modernity made

Editorial: Weight-loss drugs reveal that obesity is not a deep-seated aspect of character but something more contingent

WEKU

FDA says watch out for fake Ozempic, a diabetes drug used by many for weight loss

Thousands of fake units of the drug have been seized by the FDA, which is working alongside the manufacturer to test the counterfeit products for safety concerns.

The Independent UK

FDA warns that counterfeit Ozempic is flooding US supply chain

Officials have seized thousands of counterfeit units

Top News

FDA Seizes Thousands of Counterfeit Ozempic Shots for Diabetes

Counterfeit Ozempic diabetes drug seized by FDA, prompting concerns over identity, quality, and safety. Report suspect packages to FDA hotline.

Cycling Weekly

'I had to set two alarms at night to check my glucose to make sure I wouldn’t die': meet the revolutionary who won't stop until cycling is safer

The UCI banned his technology from races, yet Supersapiens boss Phil Southerland tells Chris Marshall-Bell he is still dead set on changing the sport in the most profound way for decades

The Independent UK

Weight loss from Lilly’s Zepbound drug reversed after stopping treatment, according to study

‘They gain back about half the weight they had originally lost over a one-year period of time,’ professor says

International Business Times

Chasing Weight Loss Dream, Many In US Seek Ozempic Alternatives

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.

1 … 20 21 22 23

People

Ineos Grenadiers

755 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.